1. Home
  2. CALC

as 04-01-2025 3:33pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

Founded: 2011 Country:
United States
United States
Employees: N/A City: LA JOLLA
Market Cap: 36.0M IPO Year: N/A
Target Price: $16.33 AVG Volume (30 days): 75.0K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.22 EPS Growth: N/A
52 Week Low/High: $1.81 - $6.27 Next Earning Date: 05-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

CALC Daily Stock ML Predictions

Share on Social Networks: